The Japanese pharmaceuticals market has undergone significant shakeup in recent years, now reaching new leagues as the third biggest pharmaceuticals market in the world.
In a recent article with Pharma Business International, Dr Andrew Rut, CEO and co-founder of MyMeds&Me, discusses the opportunities and challenges of drug safety in Japan in the face of market growth and regulatory change.
Read the article here
